pharma · Microcystic Lymphatic Malformation · Pachyonychia Congenita · PVLA
PALVELLA THERAPEUTICS
PALVELLA THERAPEUTICS, INC.
PALVELLA THERAPEUTICS trial registry — 9 ClinicalTrials.gov studies with program phase, status, and indication context.
Company details
- Status
- Public
- HQ
- Wayne, USA
- Founded
- 2015
- Employees
- 38
- Programs
- 7
- Drugs
- 0
- Patents
- 9
PALVELLA THERAPEUTICS clinical trials
Registry index of 9 ClinicalTrials.gov studies linked to PALVELLA THERAPEUTICS programs — each row shows trial ID, program name, phase, status, and indication.
PALVELLA THERAPEUTICS trial registry — 9 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for PALVELLA THERAPEUTICS.
-
PTX-022 — Phase 3
Clinical update -
QTORIN 3.9% Rapamycin Anhydrous Gel — Phase 3
Clinical update -
QTORIN 3.9% rapamycin anhydrous gel — Phase 3
Clinical update -
PTX-022 — Phase 2
Clinical update -
PTX-022 — Phase 2
Clinical update -
PTX-022 — Phase 2
Clinical update -
QTORIN 3.9% rapamycin anhydrous gel — Phase 2
Clinical update